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Abstract
Background: Genome-wide association studies (GWAS) have been used successfully in detecting associations
between common genetic variants and complex diseases. However, common SNPs detected by current GWAS
only explain a small proportion of heritable variability. With the development of next-generation sequencing
technologies, researchers find more and more evidence to support the role played by rare variants in heritable
variability. However, rare and common variants are often studied separately. The objective of this paper is to
develop a robust strategy to analyze association between complex traits and genetic regions using both common
and rare variants.
Results: We propose a weighted selective collapsing strategy for both candidate gene studies and genome-wide
association scans. The strategy considers genetic information from both common and rare variants, selectively
collapses all variants in a given region by a forward selection procedure, and uses an adaptive weight to favor
more likely causal rare variants. Under this strategy, two tests are proposed. One test denoted by BwSC is sensitive
to the directions of genetic effects, and it separates the deleterious and protective effects into two components.
Another denoted by BwSCd is robust in the directions of genetic effects, and it considers the difference of the two
components. In our simulation studies, BwSC achieves a higher power when the casual variants have the same
genetic effect, while BwSCd is as powerful as several existing tests when a mixed genetic effect exists. Both of the
proposed tests work well with and without the existence of genetic effects from common variants.
Conclusions: Two tests using a weighted selective collapsing strategy provide potentially powerful methods for
association studies of sequencing data. The tests have a higher power when both common and rare variants
contribute to the heritable variability and the effect of common variants is not strong enough to be detected by
traditional methods. Our simulation studies have demonstrated a substantially higher power for both tests in all
scenarios regardless whether the common SNPs are associated with the trait or not.
Background
Genome-wide association studies (GWAS) have been
used successfully in detecting associations between com-
mon genetic variants and complex diseases. However,
common SNPs detected by current GWAS only explain a
small proportion of heritable variability [1]. These identi-
fied common SNPs usually have a relatively small to
modest genetic effect, which suggests that another type
of variants, rare variants, need to be considered in the
current GWAS. Recent studies showed that common
diseases can be caused by causal variants with a wide
spectrum of allele frequencies including rare alleles [2-4].
In addition to the Common Diseases Common Variants
(CDCV) hypothesis underlying complex-disease etiology,
an alternative hypothesis, the Common Diseases Rare
Variants (CDRV) hypothesis has been the topic of much
recent debate [4]. Under this hypothesis, the analysis of
accumulative effect of rare variants may become crucial
in discovering the link between a candidate gene and the
heritable variability missed by the traditional GWAS.
There is increasing evidence to support this hypothesis.
For example, rare variants associated with type I diabetes
hypertension, sterol absorption and plasma levels of LDL
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that rare variants would increase the risk of disease,
recent studies also indicate that they could play a ‘protec-
tive’ role for complex traits. For example, multiple rare
variants have been shown to act protectively against type
I diabetes and hypertension [5,8,9]. With the develop-
ment of next-generation sequencing technologies, more
rare variants can be genotyped so the analysis of associa-
tion between rare variants and diseases becomes possible.
The availability of the sequencing data offers a great
opportunity to pursue a very powerful association study
considering both common and rare variants. However,
the traditional GWAS only adapts for detecting common
SNPs. Moreover, it lacks power and requires large sample
size for detecting rare variants due to their extremely low
allele frequencies. Hence, the development of more
powerful statistical tests for association studies using
both rare and common variants is needed to meet these
challenges.
Recently, a strategy that collapses all rare variants across
a causal region was proposed [10]. The idea behind this
strategy is to assume that each rare variant in a causal
region contributes equally to a disease. Therefore, collap-
sing genotypes across variants would result in enriched
association signals and a reasonably high frequency allele.
Several tests based on different collapsing strategies for
case-control studies were proposed. One is the Cohort
Allelic Sums Test (CAST) [10], in which the numbers of
individuals with one or more mutations in a group (e.g.
gene) are compared between cases and controls. While
CAST only deals with rare variants, the Combined Multi-
variate Collapsing (CMC) [11] method generalized it by
performing a multivariate test with common variants and
collapsed scores of rare variants. A weighted sum statistic
[12] is another method, which collapses both common
and rare variants by adding different weights based on
allele frequencies assuming that rare variants have a higher
effect than the common ones. One such weighted sum test
named ORWSS, whose weights are calculated based on
odd ratios, is proposed recently by Feng & Elston and Zhu
[13]. Using the regression approaches proposed by Morris
& Zeggini [14], those methods can be extended to quanti-
tative phenotypes. Besides the collapsing strategy, several
multiple-marker tests have been proposed. Two tests, SSU
and SSUw based on sum test have been proposed by Pan
[15,16], which can be applied to either common variants
or rare variants, but not both. A new adaptive sum strat-
egy proposed by Pan and Shen [17] achieves a selective
way to test regions with a few different combinations of
genetic variants, which is computationally faster and the
result depends on the order of variants. Logistic kernel-
machine-based test by Wu [18], which is based on a logis-
tic regression with a kernel function of multiple SNPs,
allows for flexible modeling of epistatic and nonlinear SNP
effects. The power of a single- marker test is usually low
due to the lack of genetic variant information and the
need for multiple testing corrections. Multiple-marker
tests may also lose power because of higher degrees of
freedom. Collapsing methods can avoid drawbacks from
both single-marker tests and multiple-marker tests by con-
sidering all the genetic variant information with only one
degree of freedom.
However, collapsing methods have their own limita-
tions and may not be robust. One limitation is that the
classification of rare variants is subjective based on a cer-
tain threshold. Tests considering only rare variants can-
not utilize genetic information of common variants and
lose some power as a consequence. Weighted sum statis-
tics [12,13] were proposed to address this issue by using
weights based on minor allele frequencies or log odds
ratios. Another limitation is that collapsing methods can
be seriously impaired by misclassification of collapsing
regions [11]. Regions can usually be defined by genes,
SNP allele frequencies, or variant causality. If all rare var-
iants within a collapsing region have the same effect on a
disease, for example deleterious effect, the association
signal can be amplified; however, if collapsing many non-
causal variants, it will introduce noise and adversely
affect power. To address this problem, several methods
have been proposed recently [19-21]. An adaptive sum
test has been proposed [19] to collapse SNPs in a region
where their effects have different directions. Each SNP
was collapsed positively or negatively based on the mar-
ginal association between a trait and itself. Some feature
selection based tests [20,21] have also been proposed for
rare variants to extract the optimal subset for collapsing
by the greedy algorithm strategy such as forward selec-
tion and backward elimination. In this article, we develop
a weighted selective collapsing method to detect both
common and rare variants in a genetic region. We argue
that common and rare variants may share a disease risk
in the same region. The proposed strategy first selectively
collapses common variants into two components repre-
senting the deleterious and protective effects by a for-
ward selection procedure according to the correlations.
Secondly, using each component as a base, the rare var-
iants are selectively combined into components with a
data-driven weight. The final test statistics are developed
through a logistic regression model for case control
studies.
The proposed strategy tries to consider all information
in a genetic region, including both common and rare
variants. It addresses the genetic direction problem by
using deleterious and protective components and over-
comes the issue of non-causal variants by applying a for-
ward selection procedure. To avoid selection bias, a
permutation procedure is employed to find the P-value.
The method is designed for candidate gene studies of
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wide association scan by applying a sliding window
strategy and be used for any type of traits through a
generalized linear model.
Results
Simulation studies
In our simulation studies, we check the type-1 error rate
and compare the power of the weighted selective collap-
sing method (denoted as BwSC and BwSCd) with several
other tests under various scenarios. The tests are classi-
fied into three categories based on genetic resources: rare
variants only, common variants only, and both rare and
common variants, denoted by R, C, and B, respectively.
There are three traditional collapsing methods: the indi-
cator, the sum, and the weighted sum, denoted byind,
sum, and wSum, respectively. For example, Rind repre-
sents the test considering only rare variants in a genetic
region using an indicator function as collapsing method
for all rare variants without any selection. BwSum is the
test using weighted sum collapsing method combining all
variants, where the weights are based on minor allele fre-
quencies. The logistic-based single marker test of a com-
mon SNP with Bonferroni correction is denoted by Cbon.
The logistic-based multiple marker test for common
SNPs is denoted by Clogit. Let Bind and Bsum represent the
logistic-based multiple marker tests using all the com-
m o nS N P sw i t ha ne x t r af a k e“common SNP”,w h i c hi s
obtained by collapsing all rare variants through the indi-
cator and the sum functions as collapsing methods. The
selective collapsing method is denoted by SC, and the
weighted selective collapsing method is denoted by wSC.
The tests which only selectively collapse rare variants are
denoted by as RSC
ind and RSC
sum.L e tBwOR be the odds ratio
b a s e dw e i g h t e ds u mt e s t .BSSU and BSSUw are SSU and
SSUw tests. BaSSU and BaSSUw are both adaptive sum tests
using SSU and SSUw as test statistics for all variants. BaS-
SUOrd and BaSSUwOrd are adaptive sum tests for ordered
variants. BKML is Logistic Kernel-Machine Test. Our pro-
posed test are denoted by BwSC and BwSCd, which selec-
tively collapse both common and rare SNPs according to
the squared correlation coefficients and with data driven
weights.
Simulated data are generated based on the strategies
used in previous studies [17,22]. A target region with
four observed common SNPs and an unobserved causal
common SNP in the middle is simulated, while 20
observed non-causal rare SNPs and 8 causal rare SNPs
are also simulated independently with common SNPs.
For each sample, common SNPs are generated based on
a latent variable Z =( Z1,...,Z5)’ from a multivariate
normal distribution with covariance structure Corr(Zi,
Zj) = 0.4 between any two observed components. Each
observed common SNP has the same chance to corre-
late with the underlying causal SNP with Corr(Zi, Z3)=
a * 0.4, where a takes values 1 and -1 with probability
0.5. Each allele on the haplotype is generated with a
minor allele frequency obtained from a uniform distri-
bution between 0.1 and 0.3. Rare variants are generated
independently with common SNPs, which are also from
a multivariate normal distribution. Within each group of
no causal rare variants and causal rare variants, LD
structure is defined by Corr(Zi, Zj)=0 . 4
|i-j|. Each allele
on a haplotype is generated with the cut-off of the
minor allele frequency obtained from a uniform distri-
bution between 0.001 and 0.005. Next, genotypes Xi =
(Xi1,...,Xi32)’ for each individual are generated by the
sum of two haplotypes. Last, the phenotype Yi is gener-
ated based on the logistic regression model with a given
odds ratio and the order of genotypes have been
shuffled. We consider five scenarios here. Scenario A is
the null case where the odds ratios for all variants are
set at 1. In Scenario B, rare variants are associated with
the trait but common variants do not. We randomly
selected eight with the customized odd ratio by para-
meter, OR between 1.3 and 3.1. Odd ratio of the half
rare variants is defined as OR and another half is
defined as OR plus one. For example, if OR is 2, then
we consider Odds Ratio = (2, 2, 2, 2, 3, 3, 3, 3) for eight
casual rare variants. In Scenario C, both common and
rare variants have effects on the traits, but effects from
common variants are not significant enough to be
detected by traditional association approaches. The odds
ratio of the unobserved causal common SNP is set at
1.5. The odds ratios for rare variants are set in the same
f a s h i o na si nS c e n a r i oB .S c e n a r i oD ,w h i c hi sq u i t e
similar to Scenario B, has a different odds ratio structure
for rare variants. The odds ratio for half of them is set
to be positive, while it is set to be negative for the rest.
For example, if OR is 2, then we consider
Odds Ratio = (2,2, 1
2, 1
2,3,3,1
3, 1
3) for eight casual rare
variants to reflect possible different genetic effect. Sce-
nario E is the counterpart version of Scenario C consid-
ering odds ratios to reflect possible different directions.
500 cases and 500 controls are simulated in the study
with 1000 simulation replicates and the significant level
was set at 0.05 for all scenarios.
Type-I error rate and Power
For tests requiring a permutation procedure, a quicker
way for calculating P- values is to simulate a large sam-
ple of test statistics from the asymptotic null distribu-
tion. We randomly select 1,000 simulation replicates
and shuffle the phenotype data 1,000 times to generate
data under the null hypotheses and compute the tests
statistics for the asymptotic null distribution. We first
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Table 1 we can see that all tests have satisfactory Type I
error rates.
Under the alternative hypothesis, we first consider the
case where all rare variants have the same genetic effect
on the trait. In scenario B, where only rare variants are
associated with the trait, we consider tests R and B, a
total of 17 tests. The result is shown in Table 2. The
proposed test BwSC achieves the highest power under
different OR. Roughly speaking, BwSC, BwSum, RSC
sum, RSC
ind
and BaSSUwOrd are the top five tests among 17 tests.
Multivariate tests with common variants and an extra
component from rare variants, Bind and Bsum,h a v el o w
power as expected, because common variants do not
contribute to the trait variability so they are just noise.
Rsum has a consistently better performance than Rind.
However, among all variants, more than half of them
are non-causal, which are also noise in this case.
Directly collapsing without any selection would lead to a
loss of power. RSC
ind and RSC
sum achieve a relative higher
power than Rind and Rsum by a selection procedure to
remove the noise from the non-causal rare variants.
BwSum, on the other hand, puts more weight on the rare
variants to reduce noise in this scenario, resulting a bet-
ter performance than previous tests. However, as shown
in the appendix, the weights based on the estimated
minor allele frequencies from controls tend to favor
those deleterious rare variants and to ignore the protec-
tive rare variants. Thus, scenario B, where all causal var-
iants are deleterious, is the optimal case for BwSum. BwSC
achieves the highest power by considering both com-
mon and rare variants with a selection procedure and a
data driven weight which could benefit both deleterious
and protective rare variants and reduce noise. BwOR has
a lower power in this simulation study, because, for a
region with the limited number of variants, we used the
weights from log odds ratios without additional thresh-
old. This may not be significantly enough to distinguish
the true signal and noise. In this simulation study, the
order of all variants is shuffled to have a fair comparison
with adaptive tests. BaSSUwOrd achieves a higher power
by sorting the genotypes according to single test statis-
tics and performs an adaptive SSUw test. BaSSUwOrd has
a consistently better performance than BSSUw and BaSSUw
in both cases. SSUw based tests have a consistently bet-
ter performance than SSU based tests.
When the effect of rare variants is relatively weak (OR
is from 1.3 to 2.2), Rind and Rsum perform better than
BaSSUwOrd. BKML and BSSU have the lowest power in this
simulation study. BKML has a consistently better perfor-
mance than BSSU. In scenario C, both common and rare
variants are associated with the trait, but the association
between common SNPs and the trait is not strong
Table 1 Type I error rates for all tests in simulated data of scenario A
Test Type-1 error Test Type-1 error Test Type-1 error Test Type-1 error
Rind 0.054 RSC
ind 0.051 BSSU 0.053 BaSSUOrd 0.06
Rsum 0.053 RSC
sum 0.054 BSSUw 0.042 BaSSUwOrd 0.062
Cbon 0.054 Bind 0.055 BaSSU 0.062 BwSC 0.042
Clogit 0.055 Bsum 0.058 BaSSUw 0.055 BwSCd 0.051
BwSum 0.055 BwOR 0.062 BKML 0.056
There is customized LD structure among common variants and among rare variants. Rind, collapsing method by indicator function on rare variants. Rsum,
collapsing method by sum function on rare variants. RSC
ind, selective Rind. RSC
sum selective Rsum . Cbon, single test with bonferroni correction on common variants.
Clogit, multivariate logistic regression test on common variants. Bind and Bsum, Clogit with collapsed component from rare variants. BwSum, weighted sum test. BwOR
Odds Ratio based weighted sum test. BSSU, BSSUw , SSU based tests. BaSSU, BaSSUw, adaptive sum tests. BaSSUOrd, BaSSUwOrd ordered adaptive sum tests. BKML, Logistic
Kernel-Machine Test. BwSC, BwSCd selectively weighted collapsing.
Table 2 Power for all tests in simulated data of scenario
B, no common SNPs effect, effects of RVs are in the same
directions
OR 1.3 1.6 1.9 2.2 2.5 2.8 3.1
Rind 0.227 0.376 0.522 0.63 0.737 0.81 0.851
Rsum 0.245 0.424 0.57 0.67 0.778 0.846 0.888
Bind 0.129 0.204 0.318 0.419 0.522 0.623 0.698
Bsum 0.147 0.243 0.343 0.47 0.565 0.674 0.751
RSC
ind 0.295 0.42 0.589 0.726 0.834 0.884 0.954
RSC
sum 0.298 0.425 0.588 0.731 0.834 0.894 0.946
BwSum 0.302 0.474 0.631 0.71 0.81 0.875 0.931
BwOR 0.09 0.17 0.226 0.295 0.416 0.408 0.58
BKML 0.044 0.054 0.057 0.067 0.08 0.074 0.078
BSSU 0.042 0.049 0.053 0.062 0.075 0.071 0.07
BSSUw 0.136 0.257 0.386 0.592 0.706 0.814 0.866
BaSSU 0.074 0.106 0.197 0.219 0.275 0.324 0.351
BaSSUw 0.161 0.243 0.378 0.504 0.691 0.755 0.823
BaSSUOrd 0.234 0.325 0.468 0.628 0.738 0.849 0.877
BaSSUwOrd 0.211 0.293 0.462 0.629 0.793 0.847 0.896
BwSCd 0.201 0.34 0.445 0.586 0.734 0.825 0.885
BwSC 0.316 0.509 0.654 0.775 0.892 0.927 0.97
There is a customized LD structure among common variants and among rare
variants.
Randomly selected eight rare variants are casual variants. Others are non-
casual variants. Genetic effect parameter OR for eight rare variants is listed in
the table. If OR is 2, Odds Ratio = (2, 2, 2,3, 3, 3) for eight casual rare variants.
Notations of tests are defined similarly those in Table 1.
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methods. We considered all 19 tests, the results are
shown in Table 3. Our test, BwSC, achieves the highest
power in most case of OR, except when OR = 1.9,
BwSum has a slight higher power. Roughly speaking, BwSC
BwSum, RSC
sum, RSC
ind and BaSSUwOrd are the top five among
19 tests. BKML and BSSU, either using a linear kernel or
without using any weights on rare variants, result in the
same power as Cbon and Clogit in this simulation study.
The results of selected tests in scenario B and C, where
all rare variants have the same genetic effect on the
trait, are shown in Figure 1 to demonstrate the
comparison.
Now, we consider scenarios D and E where rare var-
iants have different genetic effect on the trait. Tables 4
and 5 show the results of these two scenarios. BwSCd,
achieves the highest power in scenario D for most case
of OR. When OR = 1.9 and 2.8, BaSSUwOrd achieves the
highest power. When OR = 3.1, BaSSUOrd achieves the
highest power. Roughly speaking, BwSCd, BaSSUwOrd, BaS-
SUOrd, BaSSUw and BwSC are the top five tests among 17
t e s t si ns c e n a r i oD .I ns c e n a r i oE ,BwSCd and BaSSUwOrd
achieve the highest power in most cases. When OR =
1.3 and 1.6, BwOR achieves the highest power. When
OR = 1.3, 2.8 and 3.1, BaSSUwOrd has a higher power
than BwSCd. When OR = 1.6, 1.9 and 2.5, BwSCd has a
higher power. When OR = 2.2, they both achieve the
same power. Roughly speaking, BwSCd, BaSSUwOrd, BwSC,
BaSSUw and BSSUw are the top five test among 19 tests.
Being different from the results of scenarios B and C,
the power of BwSum drops significantly, because the
weights in BwSum only favor those deleterious rare var-
iants and ignore the protective rare variants, which are
as important as deleterious ones in this simulation.
Although BwOR achieves a low power because of limit
number of variants, BwOR has performed consistently
better than BwSum in most cases under both scenarios.
Due to the presence of the causal rare variants with
opposite association directions and non-causal rare var-
iants, other tests involving directly collapsing methods
also have a lower power. On the other hand, SSU and
SSUw based tests tend to perform well under these sce-
narios. BaSSUwOrd becomes one of the most powerful test
in these two scenarios. We find that SSUw based tests
combine both deleterious and protective genetic varia-
tions into the test statistic SSUw, while most collapsing
methods only consider one of them. Having the same
merit of BaSSUwOrd, our second proposed method BwSCd,
which is based on the difference of the two components,
achieves the higher power in most cases. The results of
selected tests in scenario D and E, where rare variants
have different genetic effect on the trait, are shown in
Figure 2.
Discussion
In this paper, we proposed two novel association tests
for candidate gene studies and genome wide association
studies. The test BwSC selectively collapses common and
rare variants into two separate components with data-
driven weights. The test statistic is derived by compar-
ing these components, which is robust in situations with
or without common variants. A permutation procedure
is employed to find the P-value. Simulation studies
show that the proposed tests achieve a higher power
than other commonly used tests for rare variants in
most cases. The optimal scenario for the proposed test
is that when the common and rare variants both contri-
bute to the heritable variability and effects of common
variants are not detectable by traditional methods using
common variants alone. If there is no association
between the common variants and the trait, the pro-
posed method also performs robustly as well as demon-
strated by our simulation studies. We believe that the
improved power comes from three sources. First, the
test considers more genetic information by combining
both common and rare variants instead of dealing with
rare variants alone. Second, the test filters out the
Table 3 Power for all tests in simulated data of scenario
C weak common SNPs effect, effects of RVs are in the
same direction
OR 1.3 1.6 1.9 2.2 2.5 2.8 3.1
Rind 0.237 0.394 0.472 0.6 0.715 0.785 0.843
Rsum 0.247 0.418 0.543 0.636 0.747 0.811 0.869
Cbon 0.163 0.157 0.144 0.164 0.174 0.191 0.193
Clogit 0.195 0.199 0.193 0.207 0.212 0.228 0.238
Bind 0.278 0.364 0.436 0.517 0.618 0.677 0.76
Bsum 0.298 0.384 0.461 0.562 0.668 0.735 0.795
RSC
ind 0.236 0.43 0.565 0.702 0.781 0.888 0.91
RSC
sum 0.238 0.446 0.605 0.705 0.815 0.892 0.92
BwSum 0.341 0.534 0.658 0.703 0.846 0.87 0.911
BwOR 0.253 0.312 0.344 0.475 0.456 0.582 0.648
BKML 0.167 0.186 0.186 0.19 0.204 0.199 0.2
BSSU 0.165 0.179 0.179 0.181 0.192 0.192 0.188
BSSUw 0.203 0.334 0.458 0.61 0.716 0.808 0.861
BaSSU 0.168 0.215 0.235 0.28 0.303 0.34 0.383
BaSSUw 0.181 0.346 0.399 0.546 0.64 0.755 0.819
BaSSUOrd 0.163 0.293 0.376 0.571 0.592 0.733 0.798
BaSSUwOrd 0.238 0.367 0.506 0.663 0.732 0.847 0.89
BwSCd 0.21 0.395 0.484 0.625 0.661 0.822 0.848
BwSC 0.344 0.538 0.631 0.778 0.85 0.935 0.954
There is customized LD structure among common variants and among rare
variants.
The OR for underlying common SNP is 1.5. Genetic effect parameter OR for
eight rare variants is listed in the table. If OR is 2, Odds Ratio = (2, 2, 2, 2, 3, 3,
3, 3) for eight casual rare variants. Notations of tests are defined similarly as
those in Table 1.
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variants into deleterious ones and protective ones by the
selective collapsing method. Distinguishing deleterious
and protective sources can improve the power when
variants have different genetic effect on the trait. For
example, in the worst case scenario, common variants
have a deleterious effect, while rare variants collectively
have a protective effect on the trait. The effects from
the two sources will be neutralized if the effect direc-
tions are not distinguished. Our test can achieve a high
power by choosing the strongest source in any cases
instead of neutralizing them. The third reason for the
improvement of the power comes from the data driven
weights. Instead of using weights based on estimates of
the minor allele frequencies from control data, which
favor those deleterious rare variants and ignore the pro-
tective rare variants, the proposed test uses weights
based on an estimate of the disease risk, which is the
probability of an individual with disease mutation. The
proposed weights tend to favor both deleterious and
protective rare variants.
Although the proposed test (BwSC) has many advan-
tages, it is certainly not universally better than other
tests. For example, in scenarios D and E, when the
mixed genetic effect exists, BwSC can only capture the
genetic effect in one direction. It can be used for detect-
ing variants with the same genetic effect direction.
Therefore, we also propose another test BwSCd,w h i c h
can capture all genetic effect. It can be used for detect-
ing a region of variants with opposite directions of
genetic effects. We also would like to point out that the
proposed test can be easily extended to include covari-
ates since the tests are based on a logistic regression
model. It can also be applied to quantitative traits by
using a linear regression model. The strategy that col-
lapsing rare variants based on common variants for
Figure 1 Power comparison in scenarios B and C. Selected tests are considered for power comparison in scenarios B and C, where all causal
rare variants have the same genetic effect on the trait. Scenario B is the case that only rare variants affect the traits, while Scenario C is the case
that both common and rare variants affect the traits. RSCsum represents selective Rsum. RSCind represents selective Rind. BwSum represents
weighted sum test. BaSSUwOrd represents ordered adaptive sum test with test statistics of SSUw. BwSC represents weighted selectively
collapsing test sensitive to the direction.
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to the simulated sequencing data from Genetic Analysis
Workshop 17[23], where a GWAS permutation proce-
dure of our method was proposed for qualitative trait as
well.
Conclusions
In summary, we proposed two weighted selectively col-
lapsing tests for both candidate gene studies and gen-
ome-wide association studies; in the latter case, the
analysis unit can be based on genes, pathways, or sliding
windows. The two tests are potentially powerful meth-
ods for association studies in sequencing data by com-
bining all variants information, by filtering out
suspicious non-causal variants, and by using adaptive
weight on likely causal rare variants. One test is robust
in the directions of genetic effects, and it adapts to the
region with mixed genetic effects. Another test is sensi-
tive to the directions of genetic effects, and it adapts to
the region with same genetic effect. It is designed
mainly for detecting rare variants, and it achieves a
higher power by considering common variants when
needed. Our simulation studies have demonstrated their
substantially higher power in all scenarios by combining
advantages from other existing tests.
Method
We focus on qualitative traits only in this study. It can
be easily extended to any other traits through a general-
ized linear model. Different variants and collapsing stra-
tegies are considered within the framework of logistic
regression. We also compared some recently proposed
methods, SSU tests[15], adaptive tests [17], ORWSS [13]
and Logistic Kernel-Machine Test[18] in our simulation
study. The goal of this work is to detect any association
between the trait and a given genetic region which
includes both common and rare variants. Consider an
association study with N samples in a genetic region
with K variants. Let Yi denote the coded trait for the ith
sample, 0 for controls and 1 for cases. The variants
were coded by an additive genetic model: Xik was coded
as 0, 1, and 2 as genotype scores for the kth marker of
the ith sample, where i =1 ,...,N,a n dk =1 ,...,K.
Let XC
ik and XR
ik be common variants and rare variants
based on a certain threshold. For example, SNPs with
Table 4 Power for all tests in simulated data of scenario
D, no common SNPs effect, effects of RVs are in the
different directions
OR 1.3 1.6 1.9 2.2 2.5 2.8 3.1
Rind 0.062 0.058 0.089 0.095 0.118 0.129 0.164
Rsum 0.054 0.062 0.092 0.083 0.113 0.118 0.158
Bind 0.062 0.06 0.059 0.074 0.085 0.1 0.128
Bsum 0.062 0.059 0.065 0.073 0.09 0.101 0.117
RSC
ind 0.09 0.15 0.214 0.221 0.314 0.352 0.395
RSC
sum 0.094 0.151 0.202 0.21 0.335 0.353 0.449
BwSum 0.107 0.096 0.096 0.136 0.179 0.221 0.27
BwOR 0.09 0.126 0.133 0.165 0.211 0.222 0.255
BKML 0.061 0.055 0.054 0.054 0.067 0.067 0.072
BSSU 0.056 0.053 0.052 0.05 0.062 0.062 0.068
BSSUw 0.095 0.126 0.181 0.254 0.314 0.354 0.478
BaSSU 0.086 0.087 0.13 0.138 0.167 0.162 0.229
BaSSUw 0.114 0.145 0.198 0.271 0.311 0.373 0.456
BaSSUOrd 0.113 0.175 0.241 0.289 0.39 0.409 0.566
BaSSUwOrd 0.129 0.2 0.256 0.321 0.385 0.468 0.543
BwSC 0.135 0.148 0.2 0.227 0.297 0.373 0.465
BwSCd 0.134 0.197 0.25 0.34 0.391 0.441 0.558
There is a customized LD structure among common variants and among rare
variants.
Randomly selected eight rare variants are causal variants. Others are non-causal
variants. Genetic effect parameters OR for eight rare variants are listed in the
table. Odds Ratios for another half of rare variants are in different directions. If
OR is 2,Odds Ratio = (2,2, 1
2, 1
2,3,3,1
3, 1
3)for eight casual rare
variants. Notations of tests are defined similarly as those in Table 1.
Table 5 Power for all tests in simulated data of scenario
E, weak common SNPs effect, effects of RVs are in the
different directions.
OR 1.3 1.6 1.9 2.2 2.5 2.8 3.1
Rind 0.045 0.077 0.068 0.103 0.115 0.12 0.157
Rsum 0.054 0.074 0.062 0.091 0.109 0.126 0.154
Cbon 0.156 0.131 0.155 0.139 0.186 0.149 0.146
Clogit 0.211 0.185 0.214 0.192 0.221 0.211 0.19
Bind 0.2 0.184 0.2 0.198 0.244 0.225 0.233
Bsum 0.19 0.182 0.2 0.197 0.243 0.226 0.229
RSC
ind 0.068 0.122 0.176 0.241 0.27 0.359 0.387
RSC
sum 0.094 0.119 0.193 0.254 0.273 0.371 0.39
BwSum 0.1 0.114 0.164 0.172 0.193 0.236 0.272
BwOR 0.201 0.245 0.26 0.311 0.334 0.398 0.405
BKML 0.169 0.167 0.186 0.159 0.197 0.173 0.171
BSSU 0.166 0.161 0.175 0.153 0.189 0.167 0.163
BSSUw 0.146 0.169 0.241 0.306 0.395 0.445 0.521
BaSSU 0.139 0.148 0.196 0.185 0.212 0.256 0.255
BaSSUw 0.183 0.196 0.233 0.302 0.354 0.459 0.476
BaSSUOrd 0.127 0.164 0.213 0.276 0.334 0.45 0.5
BaSSUwOrd 0.224 0.206 0.293 0.386 0.449 0.571 0.593
BwSC 0.133 0.182 0.256 0.332 0.357 0.479 0.48
BwSCd 0.19 0.217 0.308 0.386 0.468 0.568 0.548
There is a customized LD structure among common variants and among rare
variants. The OR for underlying common SNP is 1.5. Randomly selected eight
rare variants are causal variants. Others are non-causal variants. Genetic effect
parameters OR for eight rare variants are listed in the table. Odds Ratios for
half of rare variants are in different directions. If OR is 2,
Odds Ratio = (2,2, 1
2, 1
2,3,3,1
3, 1
3) for eight casual rare variants.
Notations of tests are defined similarly as those in Table 1.
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rare variants.
Collapsing Methods and Logistic Regression
Collapsing approaches have been previously proposed
using either an indicator function or a sum (proportion)
function [11,14]. Let Si denote the collapsed score for a
g e n e t i cr e g i o n .T h ei n d i c a t o rfunction based collapsing
method is Si = I(
K
k=1 XR
ik) a n dt h es u m( p r o p o r t i o n )
function based collapsing method is Si =
K
k=1 XR
ik.
I nac a s ec o n t r o ls t u d y ,i ti sn a t u r a lt oc o n s i d e rt h e
logistic regression model for tests, and those collapsing
methods can be achieved by: Logit Pr(Yi =1 )=b0,+
b1Si. The null hypothesis of no genetic effect is H0 : b1
= 0. In a candidate gene study, we employed the likeli-
hood ratio test. Because the score test is computation-
ally faster than the likelihood ratio test, we use the
following tests for the genome wide association study.
Let
U =
N 
i=1
(Yi − ¯ Y)Si
and
V = ¯ Y(1 − ¯ Y)
N 
i=1
(Si − ¯ S)
2
where ¯ Y =
 N
i=1Yi
N
and ¯ S =
 N
i=1Si
N
.
The score test is
Ts =
U2
V
Figure 2 Power comparison in scenarios D and E. Selected tests are considered for power comparison in scenarios D and E, where causal
rare variants have different genetic effect on the trait. Scenario D is the case where only rare variants affect the traits, while Scenario E is the
case where both common and rare variants affect the traits. BwSCd represents weighted selectively collapsing test robust in the direction.
BaSSUOrd represents ordered adaptive sum test with test statistics of SSU. BaSSUw represent adaptive sum test with test statistics of SSUw.
Other names of tests are defined similarly as in Figure 1.
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2 distribution with degrees
of freedom one.
The limitation of the current collapsing approaches is
that they only consider rare variants. For example, when
common variants contribute to the heritable variability
not detectable by the traditional common SNPs
approaches, ignoring them will lose power of the tests.
T h eC o m b i n e dM u l t i v a r i a t eC o l l a p s i n gm e t h o d
( C M C )[ 1 1 ]s o l v e st h i sp r o b l e mb yr e g a r d i n gc o l l a p s e d
score as a common SNP and performing a Hotelling’s
T
2 test on multiple markers. To put this method within
our logistic regression framework, we consider a multi-
variate logistic regression model.
Logit Pr(Yi =1 )=β0 + β1Si +

k
βc
kXc
ik
The null hypothesis of no genetic effect is
H0 : β1 = βc
k =0 .
Another collapsing method uses a data-driven weight
considering both common and rare variants.
Si =
K 
k=1
wkXik
where the weight is calculated by wk =
1

ˆ qk(1 − ˆ qk)
,
ˆ qk =

i∈control Xik
2N0 +2
and N0 is the number of controls in
the study [12]. By using a weight, the collapsed score
amplifies the contribution of rare variants. The test sta-
tistic can be derived from logistic regression as before.
Because the weights are data-dependent, a permutation
test is employed to find P-values.
For a region with both common and rare variants, the
above two approaches consider all the genetic informa-
tion. However, it is impossible that all variants in this
region contribute to the heritable variability, and it is
m o r el i k e l yt h a to n l ys o m eo ft h e ma r ec a u s a l .I fm a n y
of rare variants are non-casual, collapsing will inevitably
introduce noise and lose power of the test.
A covering method called RareCover [21], has been
recently proposed to determine a collapsing subset from
all the variants in this region using a forward selection
procedure. For the purpose of comparison, we also put
this strategy in our logistic regression framework.
Instead of using Pearson’s c
2, which was used by the
original authors, we considered the squared correlation
coefficient R
2 as the screening test statistic. Starting
from a score without any rare variants, each rare variant
is examined, and it is added into this score if it
improves the test statistic the most. An optimal subset
was obtained by a forward selection procedure to
achieve the highest squared correlation between the
collapsed score and traits. The test statistic then can be
derived from a logistic regression model between the
trait and the collapsed score as before. P-value can be
found by permutation. However, this method does not
consider genetic information from the common variants
in this region and it ignores the direction of the rare
variants by using either the squared correlation coeffi-
cient R
2 or Pearson’s c
2.
Recent proposed multi-marker tests
We also compared some recently proposed methods,
SSU tests[15], adaptive tests [17], ORWSS [13] and
Logistic Kernel-Machine Test[18] in our simulation stu-
dies. We briefly review these methods here. SSU and
SSUw tests are defined as follow.
Let the score vector U =( U1,...,UK), where each
component Uk =
N
i=1 Xik(Yi − ¯ Y),a n d¯ Y are the sample
mean of phenotype.
SSU = U’U And SSUw = U’Diag(If)
-1U,W h e r eIf =
Cov(U) is the expected fisher information matrix.
Asymptotic distributions of the above two test statistics
are scaled c
2 distributions[15].
For the Adaptive test, suppose that Um =( U1,...,
Um), where m<K, is the vector containing the first m
components. Adaptive test statistics is
aT = min1≤m≤KPval(T(Um))
where Pval(T(Um)) is the p-value of the test statistic,
T. For the Adaptive test, we used SSU and SSUw as the
score of the test statistics T. The adaptive tests are
called aSSU and aSSUw tests. More generally, one can
order the SNPs based on the single test statistics and
repeat the adaptive test process, resulting in the aSSU-
Ord and aSSUw-Ord. The P-value of aT is calculated by
a permutation procedure.
For the ORWSS test, the score is constructed in the
same way as other weighted sum test.
Si =
K 
k=1
wkXik
but the weight is calculated as follow.
The amended estimator of the odds ratio is computed
b ya d d i n g0 . 5t oe a c hc e l lo ft h e2b y2t a b l ef o rc a s e
control studies. If we define gk = log(ORk), where ORk is
the odds ratio for the kth marker.
wk =

γk
0
if|γk − γk| > cσ
otherwise
where s is the standard deviation calculated from gk,
k=1 ,...,K ,ci sap a r a m e t e ra n dγk is the mean of
log odds ratios[13]. In the simulation study, because
number of variants is small, we using the logarithm of
Dai et al. BMC Genetics 2012, 13:7
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classification.
Then the test statistic is defined as
ORWSS =

i∈Case
rank(Si)
P-value of ORWSS is calculated by a permutation
procedure.
For the Logistic Kernel-Machine Test, the test statis-
tics is based on logistic regression with a kernel function
of the SNPs.
Logit Pr(Yi =1 ) = β0 + h(Xi1,···,XiK)
Some commonly used kernels include linear, identity-
by-descent (IBS) and quadratic kernels. We only con-
sider the linear kernel here. In order to test whether
there is a true genetic effect, the null hypothesis is H0 :
h(X) = 0. The test statistics has been developed as
Q=
(Y − ¯ Y) K(Y − ¯ Y)
2
which follows a scaled c
2 distribution[18].
For all the tests above, we considered both common
and rare variants, since we want to develop a robust
strategy to detect any association between complex traits
and genetic regions considering both common and rare
variants.
Weighted Selective Collapsing Strategy
Now, we propose a new collapsing strategy, which con-
siders genetic information from both common and rare
variants. The new strategy tries to remove the noise
generated by the non-causal variants and to improve the
power by considering both deleterious and protective
components of this region. In brief, our strategy is as
follows. We defined rare variants as SNPs with minor
allele frequencies less than 0.01, others as common var-
iants. Starting from a null model without any variants,
b yaf o r w a r ds e l e c t i o np r o cedure, common SNPs are
first selectively collapsed into two components, which
will serve as bases for the rare variants. One is a deleter-
ious component having an extremely positive correlation
coefficient with the trait. Another is a protective compo-
nent having an extremely negative correlation coeffi-
cient. Because rare variants have high genetic effects,
they were added into the collapsed set one at a time by
a weighted sum function until either there were no var-
iants remaining, or there was no improvement of the
correlation coefficient. Repeat the forward selection pro-
cedure without common variants as the basis, two more
components were generated. Last, the collapsed score
was obtained from the four components according to
the measure of squared correlation coefficient with the
trait. The test statistic then can be derived from a logis-
tic regression model between the trait and the collapsed
score as before. P-values can be computed by
permutation.
Now, we describe the procedure in details. Assume
there are J common variants and K rare variants within
a certain predefined genomic region. Let XC
j and XR
k
denote vectors across all samples for common and rare
variants, defined by a threshold MAF = 0.01, where j =
1 ,...,J,a n dk =1 ,...,K.L e tS+ denote the deleter-
ious component, which is a vector collapsed by the sub-
set of the SNPs to achieve an extremely positive
correlation. Let S- denote the protective component,
which is a vector collapsed by the subset of the SNPs to
achieve an extremely negative correlation.
Step 1: Forward selection on common SNPs with sum
collapsing.
a) Calculate the correlation coefficient R for each
common SNP with the trait. The common SNP with
the largest correlation coefficient is added into Snew
+ ,
while the common SNP with the lowest correlation
coefficient is added into Snew
− .
Snew
+ = argmax
T+=collapes

S+,XC
j

{Cor(T+,Y)—Cor(T+,Y) > 0}
and
Snew
− = argmax
T−=collapes

S−,XC
j

{−Cor(T−,Y)—Cor(T−,Y) < 0}
where collapes(S+,XC
j ) i st h es u mo ft h ev e c t o rS+ and
XC
j , for j =1 ,...,J.
b) Update S+ and S- with Snew
+ and Snew
− .L e tj take
values only from the remaining common SNPs. Repeat
a) until either all common variants are collapsed into
components or there is no improvement for the correla-
tion coefficient of each component.
Step 2: Forward Selection on rare SNPs with weighted
sum collapsing.
a) Because rare variants have high genetic effects, the
data driven weight is derived as follows to favor the rare
variants with high genetic effect in both deleterious and
protective way.
wk =
pk 
k pk
K
where pk = |
#{yi=1,XR
ik>0}
#{XR
ik>0} − 0.5|.
XR
ik > 0 indicates a mutation for the ith sample in the
kth rare variant. pk is the empirical estimate of the prob-
ability that an individual with the mutation will have the
disease. wk is adjusted based on pk with the constraint
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variants.
b) Calculate the correlation coefficient R for each rare
SNP with the trait. The rare SNP with the largest corre-
lation coefficient is added into Snew
+ ,w h i l et h er a r eS N P
with the lowest correlation coefficient is added into Snew
− .
Snew
+ = argmaxT+=collapes(S+,XR
k)
{Cor(T+,Y)—Cor(T+,Y) > 0}
and
Snew
− = argmaxT−=collapes(S−,XR
k)
{−Cor(T−,Y)—Cor(T−,Y) < 0}
where collapes(S+,XR
k) is the sum of the vector S+ and
wkXR
k, for k =1 ,...,K.
c) Update S+ and S- with Snew
+ and Snew
− . Let k take
values only from the remaining rare SNPs. Repeat b)
until either all rare variants are collapsed into compo-
nents or there is no improvement for the correlation
coefficient of each component. The whole procedure
generates two collapsed scores SBoth
+ , SBoth
− representing
deleterious and protective components for respectively
rare variants based on common variants.
Step 3: Construct the final collapsed score. Repeat
Step2 considering rare variants only without the bases
from common variants. Thus, our test can be robust
when common SNPs are not associated with the trait. It
will generate another two components, SR
+ and SR
−.T h e
final collapsed score is derived as follow.
SwSC = argmaxT∈A{Cor(T,Y)2}
where A={SBoth
+ ,SBoth
− ,SR
+,SR
−}
T h et e s ts t a t i s t i c( w S C )c a nb ed e r i v e df r o mal o g i s t i c
regression model between the trait and the collapsed
score as before. P-values can be computed by
permutation.
SwSC is constructed by comparing the potential effect
of components in different directions. As an alternative,
we also propose a method (wSCd) to detect the genetic
effects and it is robust when the effects are in different
directions. To find wSCd, we will follow all the same
steps described before in deriving wSC, but the final col-
lapsed score is
SwSCd = argmaxT∈A{Cor(T,Y)2}
where A={SBoth
+ − SBoth
− ,SR
+ − SR
−}
Appendix
In the appendix, we show that the weight defined by
wc = 1 √
ˆ q(1−ˆ q)[12] tends to favor those deleterious rare
variants and ignore the protective rare variants. Instead
of using estimated minor allele frequencies, let q be
minor allele frequency in controls, and let p be the
minor allele frequency in case. Then w = 1 √
q(1−q),a n dw
and wc should have similar behavior.
By its definition w is a decreasing function of q, where
q Î (0, 0.5). Let R denote the odds ratio of case and
control groups and r be the minor allele frequency in all
samples for a given SNP. We have
R=
p
1 − p

q
1 − q
and
Ncasep + Ncontrolq
Ncase + Ncontrol
= r
where Ncase, Ncontrol are the number of samples in
cases, controls, respectively. The above equation can be
written as
q =r−
Ncase(p − q)
Ncase + Ncontrol
The relationship between p and q can be easily
derived based on the value of R as follows.
If R > 1,
p
1−p
	
q
1−q > 1 ⇒ p > q ⇒ q < r.
If R = 1,
p
1−p
	
q
1−q =1⇒ p > q ⇒ q=r .
If R < 1,
p
1−p
	
q
1−q < 1 ⇒ p < q ⇒ q > r.
Let w0 = 1 √
r(1−r), which is the weight for any non-cau-
sal variant (R = 1). If rare variants have deleterious
g e n e t i ce f f e c t ,t h e nR>1a n dw>w 0. If rare variants
potentially have protective genetic effect for the disease,
then R < 1 and w < w0. This shows that the weight
defined by wc = 1 √
ˆ q(1−ˆ q)[12] tends to favor those deleter-
ious rare variants and ignore the protective rare variants.
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